Amneal Pharma Issues Guidance Over Market Forecasts, But We See 3 Things Holding the Stock Back

By |2023-12-07T20:57:13+00:00April 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue [...]